Hypothesis

Engineered bacterial strains that collectively produce butyrate, indole‑3‑propionate (IPA), and spermidine can reactivate the latent germline maintenance program in aged neurons, restoring chromatin remodeling, telomerase activity, and ribosomal DNA stability, thereby improving cognitive function.

Mechanistic Rationale

• Germline cells maintain genomic integrity via high‑fidelity DNA repair, active TERT, SPR‑5/LSD1‑mediated histone demethylation, and rDNA copy‑number control [1]. These pathways are repressed but not lost in somatic neurons; longevity‑associated insulin/IGF‑1 signaling mutants can re‑express germline‑specific genes in somatic tissue, conferring stress resistance [2].
• Butyrate acts as an HDAC inhibitor, increasing histone acetylation and opening chromatin at loci silenced in neurons, potentially allowing transcription of germline‑maintenance genes [3]. IPA, a tryptophan‑derived metabolite, activates aryl hydrocarbon receptor signaling in microglia, boosting BDNF/NGF release and preserving blood‑brain barrier integrity, which creates a permissive environment for neuronal reprogramming [4].
• Spermidine, a polyamine not highlighted in the seed literature, induces autophagy and enhances mitochondrial biogenesis, further supporting the energy demands of DNA repair and telomere elongation.

Novel Integration

We propose that the three metabolites act synergistically: butyrate‑mediated chromatin loosening primes germline‑gene promoters; IPA‑driven microglial‑neuron crosstalk supplies neurotrophic support; spermidine‑induced autophagy clears damaged organelles, reducing ROS that would otherwise counteract repair. Together they mimic the intracellular milieu of a germ cell, allowing somatic neurons to access a 'germline editing budget' without the need for genetic manipulation.

Testable Predictions

1. Molecular: Aged mice receiving oral gavage of the defined consortium (butyrate‑IPA‑spermidine producers) for 8 weeks will show increased hippocampal TERT mRNA, reduced γH2AX foci, and restored rDNA copy number compared with controls receiving a single‑strain or vehicle.
2. Cellular: Single‑cell RNA‑seq of isolated neurons will reveal up‑regulation of a germline‑signature gene set (e.g., piwi‑like, dsb‑1, spo‑11) only in the triple‑treatment group.
3. Behavioral: Treated mice will outperform controls in spatial memory tasks (Morris water maze) and novel object recognition, with effect sizes correlating to the molecular biomarkers.
4. Falsifiability: If the consortium fails to produce any significant change in TERT expression, γH2AX levels, or behavioral performance relative to vehicle, the hypothesis is refuted.

Experimental Design (brief)

• Use 20‑month‑old C57BL/6J mice, n=12 per group (vehicle, butyrate‑only, IPA‑only, spermidine‑only, triple consortium).
• Administer strains daily via gavage; confirm metabolite levels in feces and plasma via LC‑MS.
• After treatment, harvest hippocampi for qPCR, immunofluorescence, and sequencing; conduct behavioral assays.
• Statistical analysis: ANOVA with post‑hoc Tukey; significance set at p<0.05.

By directly testing whether precision‑delivered metabolites can unlock a germline‑like maintenance program in neurons, this hypothesis shifts the focus from symptom‑targeted probiotics to a mechanistic rejuvenation strategy grounded in evolution’s own solution to genomic immortality.